跳至主要内容
临床试验/ISRCTN13649483
ISRCTN13649483进行中(未招募)未知

Risk reduction intervention for raised blood pressure (REVERSE): a feasibility study exploring the use of blood pressure self-monitoring

niversity of Central Lancashire0 个研究点目标入组 114 人开始时间: 2022年4月8日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
114

研究概览

简要总结

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37258072/ (added 01/06/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 18 years and over with no upper age limit
  • 2. Blood pressure between 120-139 mmHg systolic and/or 80-89 mmHg diastolic
  • 3. No previous diagnosis of hypertension

排除标准

  • 1. Prescribed anti-hypertensive medication
  • 2. Previous stroke or myocardial infarction
  • 3. Pregnancy
  • 4. Currently actively self-monitoring blood pressure
  • 5. Life-limiting illness

研究者

发起方
niversity of Central Lancashire

相似试验

Risk reduction intervention for raised blood pressure | 临床试验